Promoting Healthy and Orderly Development ofLiver Transplantation in Our Country_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

王东 , 朱继业

Corresponding author：

Keywords：

肝癌; 肝移植; 标准

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 王东,朱继业. Promoting Healthy and Orderly Development ofLiver Transplantation in Our Country. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2011, 18(4): 355-358. doi: Copy

1.	CLTR 2009 Annual Scientific Report: Liver Transplantation for Hepatocellular Carcinoma [R]. CLTR, China. www.cltr.org.
2.	Alsina AE. Liver transplantation for hepatocellular carcinoma [J]. Cancer Control, 2010, 17(2): 8386.
3.	Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? [J]. Cancer, 2000, 88(3): 538543.
4.	Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria [J]. Liver Transpl, 2002, 8(9): 765774.
5.	Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences [J]. Transplantation, 2008, 85(12): 17261732.
6.	樊嘉, 周俭, 徐泱, 等. 肝癌肝移植适应证的选择: 上海复旦标准 [J]. 中华医学杂志, 2006, 86(18): 12271231.
7.	Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis [J]. Lancet Oncol, 2009, 10(1): 3543.
8.	Lau WY. Management of hepatocellular carcinoma [J]. J R Coll Surg Edinb, 2002, 47(1): 389399.
9.	Poon RT, Fan ST, Lo CM, et al. Longterm survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation [J]. Ann Surg, 2002, 235(3): 373382.
10.	Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma [J]. Ann Surg, 2003, 238(6): 885893.
11.	Gondolesi GE, Roayaie S, Muoz L, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria [J]. Ann Surg, 2004, 239(2): 142149.
12.	Kim BW, Park YK, Kim YB, et al. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk [J]. Transplant Proc, 2008, 40(10): 35583561.
13.	Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy [J]. Ann Surg, 2003, 238(4): 508518.
14.	Maddala YK, Stadheim L, Andrews JC, et al. Dropout rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization [J]. Liver Transpl, 2004, 10(3): 449455.
15.	Pierie JP, Muzikansky A, Tanabe KK, et al. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma [J]. Ann Surg Oncol, 2005, 12(7): 552560.
16.	Gondolesi G, Muoz L, Matsumoto C, et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation [J]. J Gastrointest Surg, 2002, 6(1): 102107.
17.	Fisher RA, Kulik LM, Freise CE, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation [J]. Am J Transplant, 2007, 7(6): 16011608.
18.	Trotter JF, Adam R, Lo CM, et al. Documented deaths of hepatic lobe donors for living donor liver transplantation [J]. Liver Transpl, 2006, 12(10): 14851488.
19.	Man K, Ng KT, Lo CM, et al. Ischemiareperfusion of small liver remnant promotes liver tumor growth and metastases activation of cell invasion and migration pathways [J]. Liver Transpl, 2007, 13(12): 16691677.
20.	Hwang S, Lee SG, Alan CS, et al. Smallsized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation [J]. Transplant Proc, 2007, 39(5): 15261529.
21.	Kaihara S, Kiuchi T, Ueda M, et al. Livingdonor liver transplantation for hepatocellular carcinoma [J]. Transplantation, 2003, 75(3 Suppl): S37S40.
22.	Xu X, Ke QH, Shao ZX, et al. The value of serum alphafetoprotein in predicting tumor recurrence after liver transplantion for hepatocellular carcinoma [J]. Dig Dis Sci, 2009, 54(2): 385388.
23.	郑卫萍，郑虹，朱志军，等. 影响肝癌肝移植术后肿瘤复发转移的临床病理因素 [J]. 中国肿瘤临床, 2008, 35(12): 664667, 675.
24.	彭吉润, 赵力, 牟东成, 等. 以肿瘤睾丸抗原mRNA为特异性标记评价肝癌患者肝移植的预后 [J]. 中华普通外科杂志, 2004, 19(8): 464467.
25.	Schwartz M, Dvorchik I, Roayaie S, et al. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers [J]. J Hepatol, 2008, 49(4): 581588.
26.	徐小波, 吴李鸣, 沈炬伟, 等. MDR1基因多态性对肝癌肝移植预后的作用研究 [J]. 中国病理生理杂志, 2008, 24(3): 476480.
27.	贺轶锋, 周俭, 刘银坤, 等. 肝癌患者肝移植术后肿瘤复发相关的血清蛋白质标记物筛选 [J]. 中华器官移植杂志, 2010, 31(6): 360364.
28.	Bai DS, Dai Z, Zhou J, et al. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma [J]. Hepatology, 2009, 49(2): 460470.
29.	Vivarelli M, Cucchetti A, Piscaglia F, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression [J]. Liver Transpl, 2005, 11(5): 497503.
30.	Kneteman NM, Oberholzer J, Al Saghier M, et al. Sirolimusbased immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma [J]. Liver Transpl, 2004, 10(10): 13011311.
31.	Zhou J, Wang Z, Wu ZQ, et al. Sirolimusbased immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria [J]. Transplant Proc, 2008, 40(10): 35483553.
32.	Toso C, Merani S, Bigam DL, et al. Sirolimusbased immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma [J]. Hepatology, 2010, 51(4): 12371243.
33.	Vivarelli M, Cucchetti A, La Barba G, et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence [J]. Ann Surg, 2008, 248(5): 857862.
34.	Sotiropoulos GC, Malagó M, Molmenti E, et al. Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology [J]. Hepatogastroenterology, 2005, 52(62): 329332.

1. CLTR 2009 Annual Scientific Report: Liver Transplantation for Hepatocellular Carcinoma [R]. CLTR, China. www.cltr.org.
2. Alsina AE. Liver transplantation for hepatocellular carcinoma [J]. Cancer Control, 2010, 17(2): 8386.
3. Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? [J]. Cancer, 2000, 88(3): 538543.
4. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria [J]. Liver Transpl, 2002, 8(9): 765774.
5. Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences [J]. Transplantation, 2008, 85(12): 17261732.
6. 樊嘉, 周俭, 徐泱, 等. 肝癌肝移植适应证的选择: 上海复旦标准 [J]. 中华医学杂志, 2006, 86(18): 12271231.
7. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis [J]. Lancet Oncol, 2009, 10(1): 3543.
8. Lau WY. Management of hepatocellular carcinoma [J]. J R Coll Surg Edinb, 2002, 47(1): 389399.
9. Poon RT, Fan ST, Lo CM, et al. Longterm survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation [J]. Ann Surg, 2002, 235(3): 373382.
10. Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma [J]. Ann Surg, 2003, 238(6): 885893.
11. Gondolesi GE, Roayaie S, Muoz L, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria [J]. Ann Surg, 2004, 239(2): 142149.
12. Kim BW, Park YK, Kim YB, et al. Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk [J]. Transplant Proc, 2008, 40(10): 35583561.
13. Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy [J]. Ann Surg, 2003, 238(4): 508518.
14. Maddala YK, Stadheim L, Andrews JC, et al. Dropout rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization [J]. Liver Transpl, 2004, 10(3): 449455.
15. Pierie JP, Muzikansky A, Tanabe KK, et al. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma [J]. Ann Surg Oncol, 2005, 12(7): 552560.
16. Gondolesi G, Muoz L, Matsumoto C, et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation [J]. J Gastrointest Surg, 2002, 6(1): 102107.
17. Fisher RA, Kulik LM, Freise CE, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation [J]. Am J Transplant, 2007, 7(6): 16011608.
18. Trotter JF, Adam R, Lo CM, et al. Documented deaths of hepatic lobe donors for living donor liver transplantation [J]. Liver Transpl, 2006, 12(10): 14851488.
19. Man K, Ng KT, Lo CM, et al. Ischemiareperfusion of small liver remnant promotes liver tumor growth and metastases activation of cell invasion and migration pathways [J]. Liver Transpl, 2007, 13(12): 16691677.
20. Hwang S, Lee SG, Alan CS, et al. Smallsized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation [J]. Transplant Proc, 2007, 39(5): 15261529.
21. Kaihara S, Kiuchi T, Ueda M, et al. Livingdonor liver transplantation for hepatocellular carcinoma [J]. Transplantation, 2003, 75(3 Suppl): S37S40.
22. Xu X, Ke QH, Shao ZX, et al. The value of serum alphafetoprotein in predicting tumor recurrence after liver transplantion for hepatocellular carcinoma [J]. Dig Dis Sci, 2009, 54(2): 385388.
23. 郑卫萍，郑虹，朱志军，等. 影响肝癌肝移植术后肿瘤复发转移的临床病理因素 [J]. 中国肿瘤临床, 2008, 35(12): 664667, 675.
24. 彭吉润, 赵力, 牟东成, 等. 以肿瘤睾丸抗原mRNA为特异性标记评价肝癌患者肝移植的预后 [J]. 中华普通外科杂志, 2004, 19(8): 464467.
25. Schwartz M, Dvorchik I, Roayaie S, et al. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers [J]. J Hepatol, 2008, 49(4): 581588.
26. 徐小波, 吴李鸣, 沈炬伟, 等. MDR1基因多态性对肝癌肝移植预后的作用研究 [J]. 中国病理生理杂志, 2008, 24(3): 476480.
27. 贺轶锋, 周俭, 刘银坤, 等. 肝癌患者肝移植术后肿瘤复发相关的血清蛋白质标记物筛选 [J]. 中华器官移植杂志, 2010, 31(6): 360364.
28. Bai DS, Dai Z, Zhou J, et al. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma [J]. Hepatology, 2009, 49(2): 460470.
29. Vivarelli M, Cucchetti A, Piscaglia F, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression [J]. Liver Transpl, 2005, 11(5): 497503.
30. Kneteman NM, Oberholzer J, Al Saghier M, et al. Sirolimusbased immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma [J]. Liver Transpl, 2004, 10(10): 13011311.
31. Zhou J, Wang Z, Wu ZQ, et al. Sirolimusbased immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria [J]. Transplant Proc, 2008, 40(10): 35483553.
32. Toso C, Merani S, Bigam DL, et al. Sirolimusbased immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma [J]. Hepatology, 2010, 51(4): 12371243.
33. Vivarelli M, Cucchetti A, La Barba G, et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence [J]. Ann Surg, 2008, 248(5): 857862.
34. Sotiropoulos GC, Malagó M, Molmenti E, et al. Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology [J]. Hepatogastroenterology, 2005, 52(62): 329332.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Promoting Healthy and Orderly Development ofLiver Transplantation in Our Country

Abstract Full text Figures/Tables Video References Cited by

Format

Content